ProfileGDS5822 / ILMN_3161884
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 51% 14% 51% 21% 25% 52% 64% 32% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 122.351
GSM1276600PDAC Late Ablation Control 213.114
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 119.851
GSM1276603PDAC Late Ablation 212.521
GSM1276604PDAC Late Ablation 313.825
GSM1303940PDAC Late Ablation_anti-CTLA4 123.352
GSM1303941PDAC Late Ablation_anti-CTLA4 245.464
GSM1303942PDAC Late Ablation_anti-CTLA4 315.632